Logo image of DHAI

DIH HOLDINGS US INC (DHAI) Stock Fundamental Analysis

NASDAQ:DHAI - US23290B1061 - Common Stock

0.2575 USD
-0.01 (-2.28%)
Last: 9/2/2025, 9:38:34 AM
Fundamental Rating

1

DHAI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. DHAI has a bad profitability rating. Also its financial health evaluation is rather negative. DHAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DHAI had positive earnings in the past year.
In the past year DHAI has reported a negative cash flow from operations.
DHAI Yearly Net Income VS EBIT VS OCF VS FCFDHAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M 4M 6M

1.2 Ratios

With a decent Return On Assets value of 1.45%, DHAI is doing good in the industry, outperforming 74.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.80%, DHAI is in the better half of the industry, outperforming 74.74% of the companies in the same industry.
Industry RankSector Rank
ROA 1.45%
ROE 1.8%
ROIC N/A
ROA(3y)1.29%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DHAI Yearly ROA, ROE, ROICDHAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 -2

1.3 Margins

DHAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHAI Yearly Profit, Operating, Gross MarginsDHAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DHAI remains at a similar level compared to 1 year ago.
There is no outstanding debt for DHAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DHAI Yearly Shares OutstandingDHAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
DHAI Yearly Total Debt VS Total AssetsDHAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that DHAI is in the distress zone and has some risk of bankruptcy.
DHAI has a Altman-Z score (0.13) which is in line with its industry peers.
A Debt/Equity ratio of 0.03 indicates that DHAI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, DHAI is in the better half of the industry, outperforming 67.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACCN/A
DHAI Yearly LT Debt VS Equity VS FCFDHAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.02 indicates that DHAI may have some problems paying its short term obligations.
DHAI's Current ratio of 0.02 is on the low side compared to the rest of the industry. DHAI is outperformed by 99.47% of its industry peers.
A Quick Ratio of 0.02 indicates that DHAI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.02, DHAI is doing worse than 99.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
DHAI Yearly Current Assets VS Current LiabilitesDHAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100K 200K 300K 400K

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DHAI have decreased by -1.11% in the last year.
EPS 1Y (TTM)-1.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.86, which indicates a rather cheap valuation of DHAI.
98.95% of the companies in the same industry are more expensive than DHAI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of DHAI to the average of the S&P500 Index (27.13), we can say DHAI is valued rather cheaply.
Industry RankSector Rank
PE 2.86
Fwd PE N/A
DHAI Price Earnings VS Forward Price EarningsDHAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DHAI Per share dataDHAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DHAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIH HOLDINGS US INC

NASDAQ:DHAI (9/2/2025, 9:38:34 AM)

0.2575

-0.01 (-2.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.11%
Inst Owner Change-34.06%
Ins Owners0.45%
Ins Owner Change0%
Market Cap12.19M
AnalystsN/A
Price TargetN/A
Short Float %1.71%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.86
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.26
EV/EBITDA N/A
EPS(TTM)0.09
EY34.95%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.98
TBVpS0.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 1.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.29%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 0.13
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)102.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.36%
OCF growth 3YN/A
OCF growth 5YN/A